Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

DaVita to Sell 29 Clinics to Get Approval on CDSI Bid, U.S. Says

Sept. 2 (Bloomberg) -- DaVita Inc. must sell 29 clinics that provide dialysis services to get U.S. approval for the company’s bid to buy CDSI I Holding Co., the Federal Trade Commission said.

Competition will be preserved in 22 markets with the divestment, which is part of a proposed settlement, the FTC said in a statement.

DaVita is the Denver-based provider of outpatient dialysis services, which are used to treat people with advanced kidney disease, according to the FTC. DaVita is seeking to buy for $689 million Nashville, Tennessee-based CDSI, the fifth-largest provider of such services.

Skip Thurman, a spokesman for DaVita, didn’t immediately return phone calls seeking comment.

To contact the reporter on this story: Jeff Bliss in Washington at jbliss@bloomberg.net

To contact the editor responsible for this story: Mark Silva in Washington at msilva34@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.